USPTO serial 85959163
ONCOSPIRE GENOMICS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MIDDLETON, BERNICE L
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ONCOSPIRE GENOMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Angela C. Wilcox
ANGELA C. WILCOX VANEK, VICKERS & MASINI LLC55 W MONROE STCHICAGO, IL 60603-5001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medical and scientific research and development in the field of human disease; medical and scientific laboratory services; consulting services in the field of research, development and laboratory testing in the field of human disease; genetic research and development services; genetic testing services for research purposes; genomic research and development services; genomic testing services for research purposes; DNA screening for scientific research purposes; medical and scientific research, development and consulting in the field of oncology; medical and scientific research in the field of genetics and genetic engineering; medical and scientific research and consulting in the fields of genomics and generation sequencing; medical and scientific research in the field of cancer treatment and diagnosis; data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; conducting clinical trials for others; retrieval and correlation of genomic data; medical and scientific research relating to the design and development of cancer treatment therapies; conducting clinical and pre-clinical trials; diagnostic services in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids; research and development of identification and treatment methods for hereditary factors leading to disease; identification of target molecules for cancer treatment; proteogenomic profiling; DNA-sequencing for scientific research purposes; targeted pharmaceutical drug development services; genotyping; gene screening; gene isolation and gene expression analysis for research or analysis purposes; gene mapping; gene analysis and biomarker discovery for research or analysis purposes; providing a website featuring information related to cancer research | ACTIVE | — |
| 044 | Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation services; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing; collection and preservation of DNA for medical purposes; consulting services in the field of healthcare and cancer diagnoses; providing a website featuring health and healthcare information related to cancer research, testing and screening; genetic testing for medical purposes; genetic testing for medical diagnostic purposes; genomic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment; genetic testing for medical diagnostic purposes; genomic testing for medical diagnostic purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oncospire Genomics, LLC
- Other trademarks owned by Oncospire Genomics, LLC
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ONCOSPIRE GENOMICS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 24, 2017 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 24, 2017 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 29, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 28, 2016 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 12, 2016 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 12, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 23, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 22, 2016 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 18, 2016 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 18, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 12, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 11, 2015 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 10, 2015 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 31, 2015 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 31, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 13, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 11, 2015 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 11, 2015 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 11, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 22, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| May 23, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 21, 2014 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 21, 2014 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 21, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 18, 2014 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 21, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 21, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 1, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 13, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 10, 2013 | ALIE | ASSIGNED TO LIE | — |
| Nov 30, 2013 | ALIE | ASSIGNED TO LIE | — |
| Nov 5, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 5, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 5, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 5, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 5, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 24, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2013 | NWAP | NEW APPLICATION ENTERED | — |